Home » Stocks » Concord Medical Services

Concord Medical Services Holding Ltd. (CCM)

Stock Price: $1.79 USD -0.02 (-1.10%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $1.79 +0.00 (0.06%) Aug 7, 7:00 PM

Stock Price Chart

Key Info

Market Cap 77.75M
Revenue (ttm) 28.34M
Net Income (ttm) -43.86M
Shares Out 43.41M
EPS (ttm) -1.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $1.79
Previous Close $1.81
Change ($) -0.02
Change (%) -1.10%
Day's Open 1.79
Day's Range 1.62 - 1.82
Day's Volume 10,583
52-Week Range 1.13 - 2.92

More Stats

Market Cap 77.75M
Enterprise Value 326.66M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 43.41M
Float 13.58M
EPS (basic) n/a
EPS (diluted) -1.09
FCF / Share -2.68
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5,112
Short Ratio 0.16
Short % of Float n/a
Beta 0.24
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.74
PB Ratio 3.00
Revenue 28.34M
Operating Income 3.85M
Net Income -43.86M
Free Cash Flow -116.07M
Net Cash -248.91M
Net Cash / Share -5.73
Gross Margin 207.98%
Operating Margin 13.58%
Profit Margin -154.80%
FCF Margin -409.61%
ROA -5.08%
ROE -15.32%
ROIC -8.00%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$1.20*
Low
1.20
Current: $1.79
High
1.20
Target: 1.20
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions CNY.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue198191331455616607563456450390
Revenue Growth3.91%-42.32%-27.26%-26.19%1.58%7.77%23.59%1.23%15.56%-
Gross Profit413362564742263332345291291267
Operating Income26.9381.952264157.27182157186-161180
Net Income-307-235-284-262-78.3012585.89131-215129
Shares Outstanding130130130131135135135138142146
Earnings Per Share-12.73-8.29-6.58-6.01-1.742.761.922.85-4.542.67
EPS Growth-----43.76%-32.63%---
Dividend Per Share----0.991.61--0.17-
Dividend Growth-----38.51%-----
Operating Cash Flow-195-38.5926.73-78.08-175490259260137191
Capital Expenditures-617-641-209-107-181-82.07-142-280-258-402
Free Cash Flow-813-679-182-185-356408117-20.52-120-211
Cash & Equivalents1109066817671,2011,015834549422659
Total Debt1,8529381,1571,1091,5169041,086878205198
Net Cash / Debt-1,742-31.74-476-342-314111-252-329217461
Assets4,2974,5853,4653,2293,5942,9594,0943,6652,3932,663
Liabilities2,4082,3122,4501,9972,1601,1591,6601,325355361
Book Value-1234379341,1661,3921,7982,1222,0321,9352,205
Numbers in millions CNY, except per-share numbers.

Company Profile

Company Details

Full Name Concord Medical Services Holding Ltd.
Country China
Employees 738
CEO Jianyu Yang

Stock Information

Ticker Symbol CCM
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Care Facilities
Unique Identifier NYSE: CCM
IPO Date December 11, 2009

Description

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in Network and Hospital segments. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. It also offers other treatments and diagnostic services comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as tele-consulting services; and sells medical equipment. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of June 30, 2019, it operated a network of 30 centers based in 20 hospitals in 20 cities across 13 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.